InvivoGen
 | This article needs additional citations for verification. (March 2020) |
 | |
| Company type | Private Corporation |
|---|---|
| Industry | Manufacturing |
| Founded | 1997 |
| Founder | Gerard Tiraby |
| Headquarters | San Diego, CA, USA |
| Products |
|
| Website | www |
Invivogen is a manufacturer of life science research products. It is based in San Diego, California and conducts business worldwide.
InvivoGen is a provider of Toll-like receptor related products (mainly ligands and engineered mammalian cell lines), selection antibiotics and mycoplasma detection & elimination products. To date, about 6500 academic papers cite InvivoGen's products.
Invivogen also provides a collection of more 1000 open reading frame of human and rodent origins.
History
Invivogen was founded in 1997 in Toulouse, France.[1] The company is known for its mycoplasma detection and removal agents and its toll-like receptor product line. Although its first products focused on gene therapy, the company now produces tools for innate immunity research, immunology research, cancer research, RNA interference, cell culture, cloning and gene expression.[2] Current products are classified as: cell lines; inhibitors; vaccine adjuvants; cloning and expression; cell culture; PRR ligants; antibodies and ELIZAs; proteins and peptides; genes and promoters.[3] Invivogen also offers services for immunomodulatory compound screening and custom cloning.[4]
References
- ^ "InvivoGen LinkedIn". LinkedIn. Retrieved November 30, 2022.
- ^ "Tools for Cell Culture, Immunology and Molecular Biology". InvivoGen. 2016-09-12. Retrieved 2022-10-31.
- ^ "Tools for Cell Culture, Immunology and Molecular Biology". InvivoGen. 2016-09-12. Retrieved 2022-11-30.
- ^ "TLR and PRR Screening Service, Custom Cloning". InvivoGen. 2016-09-12. Retrieved 2022-11-30.